FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2889028305> ?p ?o ?g. }

• W2889028305 endingPage "92" @default.
• W2889028305 startingPage "81" @default.
• W2889028305 abstract "Studies are required before incorporating egg oral immunotherapy (OIT) into clinical practice. The Spanish Society of Pediatric Allergy, Asthma and Clinical Immunology (SEICAP) conducted a multicenter, randomized controlled study assessing the effectiveness and safety of the OIT using pasteurized egg white (PEW) in egg-allergic children.One hundred and one egg-allergic children (6-9 years) were randomized for 1 year: 25 to an egg-free-diet (CG) and 76 to OIT (target dose 3.3 g PEW proteins), PI (30% weekly plus 5% daily increments) or PII (only 30% weekly increments) buildup patterns. Egg skin prick test, sIgE and sIgG4 serum levels, PEW double-blind placebo-controlled food challenge (DBPCFC), and dosing adverse reactions (DARs) were evaluated in all patients from inclusion (T0) until completing 1 year of follow-up (T12). At T12, egg-allergic control patients could start OIT. The effectiveness and safety of OIT and the effect of the buildup pattern were analyzed.At T12, 4/25 (16.0%) CG patients passed the PEW DBPCFC vs 64/76 (84.2%) OIT that reached total desensitization (P = 0.000); 12 egg-allergic control patients started OIT. Finally, 72/88 (81.81%) patients reached total desensitization, 96.15% PI vs 75.80% on PII (P = 0.01). Induction period (121.12 ± 91.43, median 98.00 days) was longer in patients on PII buildup pattern, and those with allergic asthma, minor threshold dose, or higher egg sIgE (P < 0.05). Most patients (89.06%) developed DARs: 74.53% were mild; 21.90% moderate; and 3.5% requiring adrenaline-treatment. Moderate reactions and those requiring adrenaline were more frequent in patients with allergic asthma, PII pattern, or higher egg sIgE serum antibody levels (P < 0.05).PEW OIT is an effective treatment for children with persistent egg allergy. A 30% weekly plus 5% daily increment pattern could be more effective and safer than one with only 30% weekly increments." @default.
• W2889028305 created "2018-09-07" @default.
• W2889028305 creator A5006198706 @default.
• W2889028305 creator A5006347515 @default.
• W2889028305 creator A5007539719 @default.
• W2889028305 creator A5014572375 @default.
• W2889028305 creator A5016989123 @default.
• W2889028305 creator A5024297548 @default.
• W2889028305 creator A5046642713 @default.
• W2889028305 creator A5048390583 @default.
• W2889028305 creator A5056937562 @default.
• W2889028305 creator A5057349134 @default.
• W2889028305 creator A5065495035 @default.
• W2889028305 creator A5079932423 @default.
• W2889028305 creator A5080122269 @default.
• W2889028305 creator A5082765847 @default.
• W2889028305 creator A5087587596 @default.
• W2889028305 creator A5088848047 @default.
• W2889028305 creator A5090768368 @default.
• W2889028305 date "2018-11-21" @default.
• W2889028305 modified "2023-10-18" @default.
• W2889028305 title "Egg oral immunotherapy in children (SEICAP I): Daily or weekly desensitization pattern" @default.
• W2889028305 cites W1594531404 @default.
• W2889028305 cites W2000826674 @default.
• W2889028305 cites W2010233678 @default.
• W2889028305 cites W2028009915 @default.
• W2889028305 cites W2050928602 @default.
• W2889028305 cites W2057706989 @default.
• W2889028305 cites W2067224304 @default.
• W2889028305 cites W2073884835 @default.
• W2889028305 cites W2074538884 @default.
• W2889028305 cites W2100544795 @default.
• W2889028305 cites W2105938222 @default.
• W2889028305 cites W2115509572 @default.
• W2889028305 cites W2118777871 @default.
• W2889028305 cites W2132083799 @default.
• W2889028305 cites W2135920807 @default.
• W2889028305 cites W2136735111 @default.
• W2889028305 cites W2162344297 @default.
• W2889028305 cites W2278243114 @default.
• W2889028305 cites W2569125595 @default.
• W2889028305 cites W2593244680 @default.
• W2889028305 cites W4297068551 @default.
• W2889028305 doi "https://doi.org/10.1111/pai.12974" @default.
• W2889028305 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30169915" @default.
• W2889028305 hasPublicationYear "2018" @default.
• W2889028305 type Work @default.
• W2889028305 sameAs 2889028305 @default.
• W2889028305 citedByCount "21" @default.
• W2889028305 countsByYear W28890283052019 @default.
• W2889028305 countsByYear W28890283052020 @default.
• W2889028305 countsByYear W28890283052021 @default.
• W2889028305 countsByYear W28890283052022 @default.
• W2889028305 countsByYear W28890283052023 @default.
• W2889028305 crossrefType "journal-article" @default.
• W2889028305 hasAuthorship W2889028305A5006198706 @default.
• W2889028305 hasAuthorship W2889028305A5006347515 @default.
• W2889028305 hasAuthorship W2889028305A5007539719 @default.
• W2889028305 hasAuthorship W2889028305A5014572375 @default.
• W2889028305 hasAuthorship W2889028305A5016989123 @default.
• W2889028305 hasAuthorship W2889028305A5024297548 @default.
• W2889028305 hasAuthorship W2889028305A5046642713 @default.
• W2889028305 hasAuthorship W2889028305A5048390583 @default.
• W2889028305 hasAuthorship W2889028305A5056937562 @default.
• W2889028305 hasAuthorship W2889028305A5057349134 @default.
• W2889028305 hasAuthorship W2889028305A5065495035 @default.
• W2889028305 hasAuthorship W2889028305A5079932423 @default.
• W2889028305 hasAuthorship W2889028305A5080122269 @default.
• W2889028305 hasAuthorship W2889028305A5082765847 @default.
• W2889028305 hasAuthorship W2889028305A5087587596 @default.
• W2889028305 hasAuthorship W2889028305A5088848047 @default.
• W2889028305 hasAuthorship W2889028305A5090768368 @default.
• W2889028305 hasBestOaLocation W28890283051 @default.
• W2889028305 hasConcept C126322002 @default.
• W2889028305 hasConcept C142724271 @default.
• W2889028305 hasConcept C168563851 @default.
• W2889028305 hasConcept C170493617 @default.
• W2889028305 hasConcept C178790620 @default.
• W2889028305 hasConcept C185592680 @default.
• W2889028305 hasConcept C197934379 @default.
• W2889028305 hasConcept C203014093 @default.
• W2889028305 hasConcept C204787440 @default.
• W2889028305 hasConcept C207480886 @default.
• W2889028305 hasConcept C27081682 @default.
• W2889028305 hasConcept C2776027960 @default.
• W2889028305 hasConcept C2776042228 @default.
• W2889028305 hasConcept C2777752580 @default.
• W2889028305 hasConcept C2778484053 @default.
• W2889028305 hasConcept C2779779143 @default.
• W2889028305 hasConcept C3018710434 @default.
• W2889028305 hasConcept C71924100 @default.
• W2889028305 hasConcept C90924648 @default.
• W2889028305 hasConceptScore W2889028305C126322002 @default.
• W2889028305 hasConceptScore W2889028305C142724271 @default.
• W2889028305 hasConceptScore W2889028305C168563851 @default.
• W2889028305 hasConceptScore W2889028305C170493617 @default.
• W2889028305 hasConceptScore W2889028305C178790620 @default.
• W2889028305 hasConceptScore W2889028305C185592680 @default.

• next